In today’s recent session, 0.58 million shares of the Carisma Therapeutics Inc (NASDAQ:CARM) have been traded, and its beta is 1.73. Most recently the company’s share price was $0.19, and it changed around -$0.03 or -14.52% from the last close, which brings the market valuation of the company to $7.94M. CARM at last check was trading at a discount to its 52-week high of $1.90, offering almost -900.0% off that amount. The share price’s 52-week low was $0.16, which indicates that the recent value has risen by an impressive 15.79% since then.
Carisma Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.33. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended CARM as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Carisma Therapeutics Inc (NASDAQ:CARM) trade information
Instantly CARM has been showing red trend so far today with a performance of -14.52% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.2637 on recent trading dayincreased the stock’s daily price by 27.95%. The company’s shares are currently down -54.61% year-to-date, but still down -4.28% over the last five days. On the other hand, Carisma Therapeutics Inc (NASDAQ:CARM) is -1.50% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 96.83% from its current value. Analyst projections state that CARM is forecast to be at a low of $6 and a high of $6.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 42.71%. Carisma Therapeutics Inc earnings are expected to increase by 65.75% in 2025, but the outlook is positive 30.04% per year for the next five years.
CARM Dividends
Carisma Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, with 3.014% or 1.25 million shares worth $1.9 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 1.05 shares worth $0.21 million, making up 2.50% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 342.63 shares worth around $67429.0, which represents about 0.82% of the total shares outstanding.
